A potent and selective anti-tumor agent on human gastric cancer

June 29, 2009

A research article to be published on June 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Professor Yan Li from Shengjing Hospital of China Medical University studied the growth inhibitory effects of Alisol B acetat and determined its mechanism of antitumor activity in human gastric cancer cell line SGC7901.

Professor Li and his colleagues found that Alisol B acetat could inhibit the proliferation of SGC7901 cell in a time and dose dependent manner. Among the various phases of cell cycle, the percentage of cells in S phase was significantly decreased, while the percentage of cells in G1 phase was increased. Flow cytometry assay also showed Alisol B acetate had positive effect on apoptosis. Typical apoptotic morphology such as condensation and fragmentation of nuclei and formation of apoptotic bodies could be observed through electron microscope and phase-contrast microscope. Further investigating the molecular mechanism behind Alisol B acetat -induced apoptosis, cells treated with Alisol B acetat underwent a rapid loss of mitochondrial transmembrane potential, activition of caspase-3, -9, upregulation of Apaf-1 and Bax, and inhibition of the PI3K/Akt in a time-dependent manner.

The researches domenstrated for the first time that Alisol B acetate induced human gastric cancer apoptosis through regulation of mitochondrial and PI3K/AKT signaling pathways Their research results indicate that Alisol B acetate might be used to treat gastric cancer , one of the most common cancers worldwide. By knowing the mechanism of action of Alisol B acetate, it may provide a new therapeutic option, as a potential anticancer agent, in the treatment of gastric cancer.

More information: Xu YH, Zhao LJ, Li Y. Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways. World J Gastroenterol 2009; 15(23): 2870-2877. http://www.wjgnet.com/1007-9327/15/2870.asp

Source: World Journal of Gastroenterology (news : web)

Rate this story - not rated yet

rank
1
2
3
4
5

view popular

Move the slider to adjust rank threshold, so that you can hide some of the comments.

Display comments: newest first

E_L_Earnhardt - Jun 30, 2009
- Rank: not rated yet
Any evaporative reduction agent LOWERS the temperature, slows mitosis, decreases overactive electrons, returns control to mitochondria. I shrink tumors in fish by lowering temperature of water 10% below acclimitised temperature.
- report abuse
- - Current rank
  - 1
  - 2
  - 3
  - 4
  - 5

Other News

Whooping cough vaccine may be losing its punch: study

Medicine & Health / Diseases

37 minutes ago | not rated yet | 0

(PhysOrg.com) -- Vaccination programs against whooping cough may not be fully effective because the bacteria that cause the disease have evolved new strains, a new study has found. A team of Australian scientists has ...

IQ among strongest predictors of cardiovascular disease -- second only to cigarette smoking

Medicine & Health / Health

3 hours ago | not rated yet | 6 |

as reflected by low results on written or oral tests of IQ - have been associated with a raised risk of cardiovascular disease, no study has so far compared the relative strength of this association with other established ...

Communication breakdown: What happens to nerve cells in Parkinson's disease

Medicine & Health / Neuroscience

3 hours ago | not rated yet | 0 |

A new study from The Montreal Neurological Institute and Hospital - The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate. ...

A common cholesterol drug fights cataracts, too

Medicine & Health / Medications

2 hours ago | not rated yet | 1

Statins, a class of drugs used to lower cholesterol levels, have been successfully fighting heart disease for years. A new study from Tel Aviv University has now found that the same drugs cut the risks of cataracts in men ...

Changes proposed in how psychiatrists diagnose

Medicine & Health / Psychology & Psychiatry

2 hours ago | not rated yet | 0

(AP) -- Don't say "mental retardation" - the new term is "intellectual disability." No more diagnoses of Asperger's syndrome - call it a mild version of autism instead. And while "behavioral addictions" will be new to doctors' ...